Weak CEO Arrogant COO - Recensione dipendente - Associate Director presso Rocket Pharma

1,0
19 set 2021
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Almost none. There are better companies in the area. Come here, you get - Long hours and no recognition.

Svantaggi

CEO exercises minimal oversight and leadership. Has never known to stand up and take a decision. Knowledge of drug development is poor at best. Surprised he is still around. COO - Arrogant. highly distrustful, any perceived threats and triggers her rage. No empathy for anyone even her own team. She herself claims she knows it all - everything about the company and other do not know! belittles the CEO. Manages everyone by gossip. Excellent at spreading blame to others. Never claims accountability although all functions report to her. Provide any feedback and you are in for revenge. Routinely forces subordinates into unethical behavior. HR nightmare!! Medical Officer is supposed to be a founder. Shame! not a leader. Absent

Esplora altre recensioni su Rocket Pharma

5,0
9 dic 2025
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great place to work everyday.

Svantaggi

Not much, management can micromanage at times.

4,0
8 gen 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over the past year, the company has undergone a noticeable and positive evolution, with a much sharper strategic focus and a more deliberate approach to how time, talent, and resources are deployed. There is a strong and visible commitment to advancing the programs with the highest potential to meaningfully impact patients, paired with an increasing emphasis on scientific excellence, operational rigor, and disciplined execution. Teams across the organization are deeply mission-driven, collaborative, and united by a genuine sense of responsibility to patients, which consistently guides decision-making at every level. Leadership is engaged, approachable, and transparent, and has been thoughtful and decisive in setting priorities as programs progress into critical clinical, regulatory, and company-defining stages. This combination of clarity, alignment, and purpose has created real momentum and a growing sense of optimism and excitement about the company’s future and the impact its work can have.

Svantaggi

As with any growing biotech, the pace can be intense and change is constant. Priorities can shift quickly as data emerge or external factors evolve, which can be challenging at times but this reflects the reality of working at the forefront of science.

Vedi recensioni per: Utile|Valutazione|Data|Tutto